Combinatory Effects of SiRNA-induced Myostatin Inhibition and Exercise on Skeletal Muscle Homeostasis and Body Composition

Overview

Journal Physiol Rep

Specialty Physiology

Date 2014 Apr 25

PMID 24760516

Citations 11

Authors

Stephanie Mosler

Karima Relizani

Etienne Mouisel

Helge Amthor

Patrick Diel

Affiliations

Soon will be listed here.

Abstract

Abstract Inhibition of myostatin (Mstn) stimulates skeletal muscle growth, reduces body fat, and induces a number of metabolic changes. However, it remains unexplored how exercise training modulates the response to Mstn inhibition. The aim of this study was to investigate how siRNA-mediated Mstn inhibition alone but also in combination with physical activity affects body composition and skeletal muscle homeostasis. Adult mice were treated with Mstn-targeting siRNA and subjected to a treadmill-based exercise protocol for 4 weeks. Effects on skeletal muscle and fat tissue, expression of genes, and serum concentration of proteins involved in myostatin signaling, skeletal muscle homeostasis, and lipid metabolism were investigated and compared with Mstn(-/-) mice. The combination of siRNA-mediated Mstn knockdown and exercise induced skeletal muscle hypertrophy, which was associated with an upregulation of markers for satellite cell activity. SiRNA-mediated Mstn knockdown decreased visceral fat and modulated lipid metabolism similar to effects observed in Mstn(-/-) mice. Myostatin did not regulate its own expression via an autoregulatory loop, however, Mstn knockdown resulted in a decrease in the serum concentrations of myostatin propeptide, leptin, and follistatin. The ratio of these three parameters was distinct between Mstn knockdown, exercise, and their combination. Taken together, siRNA-mediated Mstn knockdown in combination with exercise stimulated skeletal muscle hypertrophy. Each intervention or their combination induced a specific set of adaptive responses in the skeletal muscle and fat metabolism which could be identified by marker proteins in serum.

Citing Articles

Modified fibrin hydrogel for sustained delivery of RNAi lipopolyplexes in skeletal muscle.

Ngarande E, Doubell E, Tamgue O, Mano M, Human P, Giacca M Regen Biomater. 2023; 10:rbac101.

PMID: 36726610 PMC: 9887344. DOI: 10.1093/rb/rbac101.

Myostatin Alteration in Pigs Enhances the Deposition of Long-Chain Unsaturated Fatty Acids in Subcutaneous Fat.

Pei Y, Song Y, Feng Z, Li H, Mu Y, Rehman S Foods. 2022; 11(9).

PMID: 35564009 PMC: 9105368. DOI: 10.3390/foods11091286.

Molecular Mechanisms of Exercise and Healthspan.

Guan Y, Yan Z Cells. 2022; 11(5).

PMID: 35269492 PMC: 8909156. DOI: 10.3390/cells11050872.

Interaction of Fibromodulin and Myostatin to Regulate Skeletal Muscle Aging: An Opposite Regulation in Muscle Aging, Diabetes, and Intracellular Lipid Accumulation.

Lee E, Ahmad S, Lim J, Ahmad K, Shaikh S, Lee Y Cells. 2021; 10(8).

PMID: 34440852 PMC: 8393414. DOI: 10.3390/cells10082083.

Peptide-2 from mouse myostatin precursor protein alleviates muscle wasting in cancer-associated cachexia.

Ojima C, Noguchi Y, Miyamoto T, Saito Y, Orihashi H, Yoshimatsu Y Cancer Sci. 2020; 111(8):2954-2964.

PMID: 32519375 PMC: 7419029. DOI: 10.1111/cas.14520.

References

Haskell W . The influence of exercise on the concentrations of triglyceride and cholesterol in human plasma. Exerc Sport Sci Rev. 1984; 12:205-44. View

Bradley L, Yaworsky P, Walsh F . Myostatin as a therapeutic target for musculoskeletal disease. Cell Mol Life Sci. 2008; 65(14):2119-24. PMC: 11131841. DOI: 10.1007/s00018-008-8077-3. View

Liu C, Yang Z, Liu C, Wang R, Tien P, Dale R . Myostatin antisense RNA-mediated muscle growth in normal and cancer cachexia mice. Gene Ther. 2007; 15(3):155-60. DOI: 10.1038/sj.gt.3303016. View

Mosler S, Geisler S, Hengevoss J, Schiffer T, Piechotta M, Adler M . Modulation of follistatin and myostatin propeptide by anabolic steroids and gender. Int J Sports Med. 2013; 34(7):567-72. DOI: 10.1055/s-0032-1312585. View

Amthor H, Hoogaars W . Interference with myostatin/ActRIIB signaling as a therapeutic strategy for Duchenne muscular dystrophy. Curr Gene Ther. 2012; 12(3):245-59. DOI: 10.2174/156652312800840577. View

Cambri L, de Araujo G, Ghezzi A, Botezelli J, Mello M . Metabolic responses to acute physical exercise in young rats recovered from fetal protein malnutrition with a fructose-rich diet. Lipids Health Dis. 2011; 10:164. PMC: 3196910. DOI: 10.1186/1476-511X-10-164. View

Diel P, Schiffer T, Geisler S, Hertrampf T, Mosler S, Schulz S . Analysis of the effects of androgens and training on myostatin propeptide and follistatin concentrations in blood and skeletal muscle using highly sensitive immuno PCR. Mol Cell Endocrinol. 2010; 330(1-2):1-9. DOI: 10.1016/j.mce.2010.08.015. View

Matsakas A, Macharia R, Otto A, Elashry M, Mouisel E, Romanello V . Exercise training attenuates the hypermuscular phenotype and restores skeletal muscle function in the myostatin null mouse. Exp Physiol. 2011; 97(1):125-40. DOI: 10.1113/expphysiol.2011.063008. View

Matsakas A, Mouisel E, Amthor H, Patel K . Myostatin knockout mice increase oxidative muscle phenotype as an adaptive response to exercise. J Muscle Res Cell Motil. 2010; 31(2):111-25. DOI: 10.1007/s10974-010-9214-9. View

10.

McPherron A . METABOLIC FUNCTIONS OF MYOSTATIN AND GDF11. Immunol Endocr Metab Agents Med Chem. 2011; 10(4):217-231. PMC: 3011861. DOI: 10.2174/187152210793663810. View

11.

McPherron A, Lawler A, Lee S . Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature. 1997; 387(6628):83-90. DOI: 10.1038/387083a0. View

12.

Savage K, McPherron A . Endurance exercise training in myostatin null mice. Muscle Nerve. 2010; 42(3):355-62. PMC: 2976492. DOI: 10.1002/mus.21688. View

13.

Mosler S, Pankratz C, Seyfried A, Piechotta M, Diel P . The anabolic steroid methandienone targets the hypothalamic-pituitary-testicular axis and myostatin signaling in a rat training model. Arch Toxicol. 2011; 86(1):109-19. DOI: 10.1007/s00204-011-0740-z. View

14.

Wang Q, McPherron A . Myostatin inhibition induces muscle fibre hypertrophy prior to satellite cell activation. J Physiol. 2012; 590(9):2151-65. PMC: 3447157. DOI: 10.1113/jphysiol.2011.226001. View

15.

Cirak S, Arechavala-Gomeza V, Guglieri M, Feng L, Torelli S, Anthony K . Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study. Lancet. 2011; 378(9791):595-605. PMC: 3156980. DOI: 10.1016/S0140-6736(11)60756-3. View

16.

McPherron A, Lee S . Suppression of body fat accumulation in myostatin-deficient mice. J Clin Invest. 2002; 109(5):595-601. PMC: 150888. DOI: 10.1172/JCI13562. View

17.

Mosler S, Relizani K, Mouisel E, Amthor H, Diel P . Combinatory effects of siRNA-induced myostatin inhibition and exercise on skeletal muscle homeostasis and body composition. Physiol Rep. 2014; 2(3):e00262. PMC: 4002242. DOI: 10.1002/phy2.262. View

18.

Velders M, Schleipen B, Fritzemeier K, Zierau O, Diel P . Selective estrogen receptor-β activation stimulates skeletal muscle growth and regeneration. FASEB J. 2012; 26(5):1909-20. DOI: 10.1096/fj.11-194779. View

19.

Amthor H, Macharia R, Navarrete R, Schuelke M, Brown S, Otto A . Lack of myostatin results in excessive muscle growth but impaired force generation. Proc Natl Acad Sci U S A. 2007; 104(6):1835-40. PMC: 1794294. DOI: 10.1073/pnas.0604893104. View

20.

Kinouchi N, Ohsawa Y, Ishimaru N, Ohuchi H, Sunada Y, Hayashi Y . Atelocollagen-mediated local and systemic applications of myostatin-targeting siRNA increase skeletal muscle mass. Gene Ther. 2008; 15(15):1126-30. DOI: 10.1038/gt.2008.24. View